Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

149-157 (Activation loop from InterPro)

Target domain

10-314 (Protein kinase domain)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

0 structures for Q5UQC1

Entry ID Method Resolution Chain Position Source

No variants for Q5UQC1

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5UQC1

No associated diseases with Q5UQC1

2 regional properties for Q5UQC1

Type Name Position InterPro Accession
domain Protein kinase domain 10 - 314 IPR000719
active_site Tyrosine-protein kinase, active site 129 - 141 IPR008266

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

3 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
protein serine/threonine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.

1 GO annotations of biological process

Name Definition
protein phosphorylation The process of introducing a phosphate group on to a protein.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSNNIFTNNY TIVDKLSEGT YGIVYKVEHI ESKKNFACKK FVIDNNFTYC NYNELIAHNE
70 80 90 100 110 120
FNHSNLIEIY DILVDYGHDK CTYYVIMELC DGCLFDILFC DKVFLDESQR LDYLIQIIDG
130 140 150 160 170 180
LEYMWSKGFV HNDLSLTNIL VKNNKIKIAD FGFMYNRFIK QDIYHRNTIY IQPPELISGH
190 200 210 220 230 240
PRICDPNKID TWALGQIFYV MCYNSVLYNY SNKTDYYLDI ISKTNTPSLD IIDKLYLSDK
250 260 270 280 290 300
YKKLYYNIFR KNIKKLTQNA INELVCYNKS TNKFSNDNLR KKTSSNKFIK KHMNWSVRHR
310 320 330 340 350 360
PDIKQSRKLF YEILANKYPI YNSPIIQSII PSTISFREFS FHKLWSSMNN YDYLFKSNLL
370 380 390 400 410 420
FGIHFEYKIR LHHRFDYQYN LIVKIMLLMG KIIRSCFSKY NKFKCLNKFI YPNNNYLLSS
430 440 450 460 470 480
QISRLENSFD RFYSMGKIIY CHYPFFENYI FDYDTIKLSN SLEFQYHFID ILDKEIPCLD
490 500 510 520 530 540
AYDIFLLSNC NKMYQKYFKY MYYLFVSSPN ATVFDNNIVY QSIMLIIISY KNSLIYKKLI
550 560 570 580 590 600
NQFLKLNIST KIKYSREINH CFNDDIINVI EIDNDYGINL NYFTVDTIIT AYYIIHICRL
610 620 630
ITNEKYNLLN INFAIESKFI KYLDKLVSVI DME